Author:
Garcia Vincent,Vig Véronique,Peillard Laurent,Ramdani Alaa,Mohamed Sofiane,Halfon Philippe
Abstract
AbstractFollowing the outbreak of the SARS-CoV2 virus worldwide in 2019, the rapid widespread overtime of variants suggests today an undergoing positive selection of variants which could potentially provide advantageous genetic property of the virus. Numerous variants have already been described across different countries including N501Y, E484K or L452R mutations on gene coding to spike protein. Most recently, 2 new Indian variants with N440K and E484Q and L452R mutations associated with impaired antibody response and immune reactions were identified in India. The potential consequences of emerging variants are increased transmissibility, increased pathogenicity and the ability to escape natural or vaccine-induced immunity.We described for the first time in France both variants: the N440K immune escape variant within a new strain detected in France in a couple of patients who did not have any history of travel abroad and the new E484Q and L452R Indian variant from a patient travelling from Indian to Marseille to embark on a ship as a crew member.Such study of the circulating viral strains and their variants within the increasing number of infected people worldwide will provide further insights into the viral dissemination. Hence, real time close monitoring variant could help the scientific community to prevent fast-spreading and raise alarms towards potentially harmful variants.
Publisher
Cold Spring Harbor Laboratory
Reference5 articles.
1. Weisblum Y , Schmidt F , Zhang F , DaSilva J , Poston D , Lorenzi JCC , et al. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. bioRxiv [Internet]. 22 juill 2020 [cité 2 avr 2021]; Disponible sur: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386497/
2. Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization;Cell Host Microbe,2021
3. Nonaka CKV , Franco MM , Gräf T , de Lorenzo Barcia CA , de Ávila Mendonça RN , de Sousa KAF , et al. Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil. Emerg Infect Dis. 19 févr 2021;27(5).
4. Deng X , Garcia-Knight MA , Khalid MM , Servellita V , Wang C , Morris MK , et al. Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation. medRxiv [Internet]. 9 mars 2021 [cité 2 avr 2021]; Disponible sur: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987058/
5. Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India | bioRxiv [Internet]. [cité 5 mai 2021]. Disponible sur: https://www.biorxiv.org/content/10.1101/2021.04.22.440932v1
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献